title: HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancers.
authors.affiliation: Division of Oncology, University of Washington, Seattle, Washington 98195, USA.
authors.forename: K
authors.initials: K
authors.lastname: Schiffman
authors.forename: M L
authors.initials: ML
authors.lastname: Disis